11673-632 : Up and Up Hair Regrowth Treatment for Men 5 g/100ml Topical Solution
NDC: | 11673-632 |
Labeler: | Target Corporation |
Product Type: | Human OTC Drug |
Drug Name: | Up and Up Hair Regrowth Treatment for Men |
Dosage Form: | Topical Solution |
Application #: | ANDA075598 |
Rev. Date: |
NDC Package Codes:
- 11673-632-30: 3 BOTTLE IN 1 CARTON (11673‑632‑30) > 60 ML IN 1 BOTTLE (11673‑632‑16)
Active Ingredients:
- Minoxidil
Dosage Strength:
- 5 g/100mL
Pharmaceutical Classes:
- Arteriolar Vasodilation [PE]
- Arteriolar Vasodilator [EPC]
Related Products:
Based on records with the same trade name.- 11673-317 Up and Up Hair Regrowth Treatment for Men 5 g/100ml Topical Solution by Target Corporation
- 11673-707 Up and Up Hair Regrowth Treatment for Men 5 g/100g Topical Aerosol, Foam by Target Corporation
- 11673-798 Up and Up Hair Regrowth Treatment for Men 3 g/60ml Topical Solution by Target Corporation
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 11673-631Next: 11673-633 >
Related Discussions:
Warning! Interaction Between Propranolol + Minoxidil (Rogaine)
Hi, I was taking propranolol to help with anxiety. Dosage was dependent on how bad anxiety was on any given day. I was s... 1 reply
Hi, I was taking propranolol to help with anxiety. Dosage was dependent on how bad anxiety was on any given day. I was s... 1 reply
2 Minoxidil Aminexil Topical Solution
i want to know if the solution is safe to use for hair fall treatment and what precautions to be taken while using it....
i want to know if the solution is safe to use for hair fall treatment and what precautions to be taken while using it....
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.